Swedish firm Bactiguard receives grant to develop new vascular stents that will reduce blood clot risk
Swedish medical device company Bactiguard has won a grant to develop metal-coated vascular stents to reduce the risk of blood clots that may lead to strokes and heart attack.
More From BioPortfolio on "Swedish firm Bactiguard receives grant to develop new vascular stents that will reduce blood clot risk"